Prevention of respiratory syncytial virus infection in infants - Palivizumab is effective but too expensive, and vaccines are unavailable as yet

被引：15

作者：

Handforth, J ^{[1
]}

Sharland, M

Friedland, JS

机构：

[1] Univ London St Georges Hosp, Paediat Infect Dis Unit, London SW17 0QT, England

[2] Hammersmith Hosp, Imperial Coll Sch Med, Dept Infect Dis, London W12 0NN, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 328卷 / 7447期

关键词：

D O I：

10.1136/bmj.328.7447.1026

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1026 / 1027

页数：2

共 12 条

[1]

*AM AC PED, 2003, RED BOOK 2003 REP CO, P523

[2] CURRENT APPROACHES TO THE DEVELOPMENT OF VACCINES AGAINST DISEASE CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS (PIV) - A MEETING REPORT OF THE WHO PROGRAM FOR VACCINE DEVELOPMENT [J].

CROWE, JE .

VACCINE, 1995, 13 (04) :415-421

[3] Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease [J].

Feltes, TF ;

Cabalka, AK ;

Meissner, C ;

Piazza, FM ;

Carlin, DA ;

Top, FH ;

Connor, EM ;

Sondheimer, HM .

JOURNAL OF PEDIATRICS, 2003, 143 (04) :532-540

[4]

Fleming DM, 2003, BRIT J GEN PRACT, V53, P778

[5] Bovine parainfluenza virus type 3 (PIV3) expressing the respiratory syncytial virus (RSV) attachment and fusion proteins protects hamsters from challenge with human PIV3 and RSV [J].

Haller, AA ;

Mitiku, M ;

MacPhail, M .

JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2153-2162

[6]

Handforth J, 2000, Paediatr Respir Rev, V1, P210, DOI 10.1053/prrv.2000.0050

[7]

*JOINT COMM VACC I, 2002, JOINT COMM VACC IMM

[8] RESPIRATORY SYNCYTIAL VIRUS DISEASE IN INFANTS DESPITE PRIOR ADMINISTRATION OF ANTIGENIC INACTIVATED VACCINE [J].

KIM, HW ;

CANCHOLA, JG ;

BRANDT, CD ;

PYLES, G ;

CHANOCK, RM ;

JENSEN, K ;

PARROTT, RH .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 1969, 89 (04) :422-+

[9] Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998 [J].

Müller-Pebody, B ;

Edmunds, WJ ;

Zambon, MC ;

Gay, NJ ;

Crowcroft, NS .

EPIDEMIOLOGY AND INFECTION, 2002, 129 (01) :99-106

[10] Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women [J].

Munoz, FM ;

Piedra, PA ;

Glezen, WP .

VACCINE, 2003, 21 (24) :3465-3467

← 1 2 →